Healthcare & Life Sciences
EnLiven Therapeutics
series-c-plus
series-c-plus
Stage
1
Investors
About
EnLiven Therapeutics is a biopharmaceutical company focused on developing novel therapeutics to treat fibrotic diseases.
Explore EnLiven Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.